Search Results - "стимуляция яичников"

1

Academic Journal

Venous and arterial thromboses in ART programs: epidemiology and preventive strategies ; Венозные и артериальные тромбозы в программах ВРТ: эпидемиология и превентивные стратегии

Authors: V. O. Bitsadze, J. Kh. Khizroeva, E. Grandone, R. I. Gabidullina, M. V. Tretyakova, N. A. Makatsariya, N. R. Gashimova, K. N. Grigoreva, A. V. Vorobev, A. V. Lazarchuk, M. M. Muravyova, A. G. Krendeleva, T. E. Polyakova, M. S. Zainulina, D. L. Kapanadze, F. E. Yagubova, J.-C. Gris, I. Elalamy, G. Gerotziafas, P. Van Dreden, A. D. Makatsariya, В. О. Бицадзе, Д. Х. Хизроева, Э. Грандоне, Р. И. Габидуллина, М. В. Третьякова, Н. А. Макацария, Н. Р. Гашимова, К. Н. Григорьева, А. В. Воробьев, А. В. Лазарчук, М. М. Муравьёва, А. Г. Кренделева, Т. Е. Полякова, М. С. Зайнулина, Д. Л. Капанадзе, Ф. Э. Ягубова, Ж.-К. Гри, И. Элалами, Г. Геротзиафас, П. Ван Дреден, А. Д. Макацария

Contributors: The authors declare no funding, Авторы заявляют об отсутствии финансовой поддержки

Source: Obstetrics, Gynecology and Reproduction; Vol 19, No 3 (2025); 377-388 ; Акушерство, Гинекология и Репродукция; Vol 19, No 3 (2025); 377-388 ; 2500-3194 ; 2313-7347

File Description: application/pdf

Relation: https://www.gynecology.su/jour/article/view/2494/1346; Calhaz-Jorge C., De Geyter C.H., Kupka M.S. et al. Survey on ART and IUI: legislation, regulation, funding and registries in European countries: The European IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod Open. 2020;2020(1):hoz044. https://doi.org/10.1093/hropen/hoz044.; European IVF Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE); Smeenk J., Wyns C., De Geyter C. et al. ART in Europe, 2019: results generated from European registries by ESHRE. Hum Reprod. 2023;3(12):2321–38. https://doi.org/10.1093/humrep/dead197.; Farquhar C., Marjoribanks J., Brown J. et al. Management of ovarian stimulation for IVF: narrative review of evidence provided for World Health Organization guidance. Reprod Biomed Online. 2017;35(1):3–16. https://doi.org/10.1016/j.rbmo.2017.03.024.; Nelson S.M. Venous thrombosis during assisted reproduction: novel risk reduction strategies. Thromb Res. 2013;131 Suppl 1:S1–3. https://doi.org/10.1016/S0049-3848(13)00023-6.; Grandone E., Villani M. Assisted reproductive technologies and thrombosis. Thromb Res. 2015;135 Suppl 1:S44–5. https://doi.org/10.1016/S0049-3848(15)50441-6.; Kupka M.S., Ferraretti A.P., de Mouzon J. et al.; European IVF-Monitoring Consortium, for the European Society of Human Reproduction and Embryology. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE†. Hum Reprod. 2014;29(10):2099–113. https://doi.org/10.1093/humrep/deu175.; Sennström M., Rova K., Hellgren M. et al. Thromboembolism and in vitro fertilization – a systematic review. Acta Obstet Gynecol Scand. 2017;96(9):1045–52. https://doi.org/10.1111/aogs.13147.; Practice Committee of American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil Steril. 2008;90(5 Supple):S188–93. https://doi.org/10.1016/j.fertnstert.2008.08.034.; Grandone E., Colaizzo D., Vergura P. et al. Age and homocysteine plasma levels are risk factors for thrombotic complications after ovarian stimulation. Hum Reprod. 2004;19(8):1796–9. https://doi.org/10.1093/humrep/deh346.; Henriksson P., Westerlund E., Wallén H. et al. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilisation: cross sectional study. BMJ. 2013;346:е8632. https://doi.org/10.1136/bmj.e8632.; Rova K., Passmark H., Lindqvist P.G. Venous thromboembolism in relation to in vitro fertilization: an approach to determining the incidence and increase in risk in successful cycles. Fertil Steril. 2012;97(1):95–100. https://doi.org/10.1016/j.fertnstert.2011.10.038.; Nelson S.M. Prophylaxis of VTE in women – during assisted reproductive techniques. Thromb Res. 2009;123 Suppl 3:S8–S15. https://doi.org/10.1016/S0049-3848(09)70127-6.; Hansen A.T., Kesmodel U.S., Juul S., Hvas A.M. No evidence that assisted reproduction increases the risk of thrombosis: a Danish national cohort study. Hum Reprod. 2012;27(5):1499–503. https://doi.org/10.1093/humrep/des041.; Serour G.I., Aboulghar M., Mansour R. et al. Complications of medically assisted conception in 3,500 cycles. Fertil Steril. 1998;70(4):638–42. https://doi.org/10.1016/s0015-0282(98)00250-7.; Girolami A., Scandellari R., Tezza F. et al. Arterial thrombosis in young women after ovarian stimulation: case report and review of the literature. J Thromb Thrombolysis. 2007;24(2):169–74. https://doi.org/10.1007/s11239-007-0009-9.; Chan W.S. The 'ART' of thrombosis: a review of arterial and venous thrombosis in assisted reproductive technology. Curr Opin Obstet Gynecol. 2009;21(3):207–18. https://doi.org/10.1097/GCO.0b013e328329c2b8.; Yang S., Yuan J., Qin W. et al. The clinical characteristics of acute cerebrovascular accidents resulting from ovarian hyperstimulation syndrome. Eur Neurol. 2017;77(5–6):221–30. https://doi.org/10.1159/000463383.; Filipovic-Pierucci A., Gabet A., Deneux-Tharaux C. et al. Arterial and venous complications after fertility treatment: a French nationwide cohort study. Eur J Obstet Gynecol Reprod Biol. 2019;237:57–63. https://doi.org/10.1016/j.ejogrb.2019.02.034.; Chan W.S, Dixon M.E. The "ART" of thromboembolism: a review of assisted reproductive technology and thromboembolic complications. Thromb Res. 2008;121(6):713–26. https://doi.org/10.1016/j.thromres.2007.05.023.; Villani M., Favuzzi G., Totaro P. et al. Venous thromboembolism in assisted reproductive technologies: comparison between unsuccessful versus successful cycles in an Italian cohort. J Thromb Thrombolysis. 2018;45(2):234–9. https://doi.org/10.1007/s11239-017-1584-z.; Mozes M., Bogokowsky H., Antebi E. et al. Thromboembolic phenomena after ovarian stimulation with human gonadotrophins. Lancet. 1965;2(7424):1213–5. https://doi.org/10.1016/s0140-6736(65)90636-7.; Kermode A.G., Churchyard A., Carroll W.M. Stroke complicating severe ovarian hyperstimulation syndrome. Aust N Z J Med. 1993;23(2):219–20. https://doi.org/10.1111/j.1445-5994.1993.tb01823.x.; Inbar O.J., Levran D., Mashiach S., Dor J. Ischemic stroke due to induction of ovulation with clomiphene citrate and menotropins without evidence of ovarian hyperstimulation syndrome. Fertil Steril. 1994;62(5):1075–6. https://doi.org/10.1016/s0015-0282(16)57078-2.; Cluroe A.D., Synek B.J. A fatal case of ovarian hyperstimulation syndrome with cerebral infarction. Pathology. 1995;27(4):344–6. https://doi.org/10.1080/00313029500169273.; Chan W.S., Ginsberg J.S. A review of upper extremity deep vein thrombosis in pregnancy: unmasking the 'ART' behind the clot. J Thromb Haemost. 2006;4(8):673–7. https://doi.org/10.1111/j.1538-7836.2006.02026.x.; Fleming T., Sacks G., Nasser J. Internal jugular vein thrombosis following ovarian hyperstimulation syndrome. Aust N Z J Obstet Gynaecol. 2012;52(1):87–90. https://doi.org/10.1111/j.1479-828X.2011.01392.x.; Salomon O., Schiby G., Heiman Z. et al. Combined jugular and subclavian vein thrombosis following assisted reproductive technology – new observation. Fertil Steril. 2009;92(2):620–5. https://doi.org/10.1016/j.fertnstert.2008.07.1708.; Aboulghar M.A., Mansour R.T., Serour G.I., Amin Y.M. Moderate ovarian hyperstimulation syndrome complicated by deep cerebrovascular thrombosis. Hum Reprod. 1998;13(8):2088–91. https://doi.org/10.1093/humrep/13.8.2088.; Kodama H., Fukuda J., Karube H. et al. Characteristics of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome who actually developed thromboembolism. Fertil Steril. 1995;64(6):1207–9. https://doi.org/10.1016/s0015-0282(16)57987-4.; Delvigne A., Demoulin A., Smitz J. et al. The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study. I. Clinical and biological features. Hum Reprod. 1993;8(9):1353–60. https://doi.org/10.1093/oxfordjournals.humrep.a138260.; Dulitzky M., Cohen S.B., Inbal A. et al. Increased prevalence of thrombophilia among women with severe ovarian hyperstimulation syndrome. Fertil Steril. 2002;77(3):463–7. https://doi.org/10.1016/s0015-0282(01)03218-6.; Grandone E., Di Micco P.P., Villani M. et al.; RIETE Investigators. Venous thromboembolism in women undergoing assisted reproductive technologies: Data from the RIETE Registry. Thromb Haemost. 2018;118(11):1962–8. https://doi.org/10.1055/s-0038-1673402.; Olausson N., Discacciati A., Nyman A.I. et al. Incidence of pulmonary and venous thromboembolism in pregnancies after in vitro fertilization with fresh respectively frozen-thawed embryo transfer: nationwide cohort study. J Thromb Haemost. 2020;18(8):1965–73. https://doi.org/10.1111/jth.14840.; Abramov Y., Elchalal U., Schenker J.G. Obstetric outcome of in vitro fertilized pregnancies complicated by severe ovarian hyperstimulation syndrome: a multicenter study. Fertil Steril. 1998;70(6):1070–6. https://doi.org/10.1016/s0015-0282(98)00350-1.; Bauersachs R.M., Manolopoulos K., Hoppe I. et al. More on: the 'ART' behind the clot: solving the mystery. J Thromb Haemost. 2007;5(2):438–9.; Richardson M.A., Berg D.T., Calnek D.S. et al. 17beta-estradiol, but not raloxifene, decreases thrombomodulin in the antithrombotic protein C pathway. Endocrinology. 2000;141(10):3908–11. https://doi.org/10.1210/endo.141.10.7798.; Rogolino A., Coccia M.E., Fedi S. et al. Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. Blood Coagul Fibrinolysis. 2003;14(3):277–82. https://doi.org/10.1097/01.mbc.0000061296.28953.d0.; Ricci G., Bogatti P., Fischer-Tamaro L. et al. Factor V Leiden and prothrombin gene G20210A mutation and in vitro fertilization: prospective cohort study. Hum Reprod. 2011;26(11):3068–77. https://doi.org/10.1093/humrep/der261.; Goualou M., Noumegni S., de Moreuil C. et al. Venous thromboembolism associated with assisted reproductive technology: a systematic review and meta-analysis. Thromb Haemost. 2023;123(3):283–94. https://doi.org/10.1055/s-0042-1760255.; Pabinger I., Grafenhofer H., Kaider A. et al. Risk of pregnancy-associated recurrent venous thromboembolism in women with a history of venous thrombosis. J Thromb Haemost. 2005;3(5):949–54. https://doi.org/10.1111/j.1538-7836.2005.01307.x.; Milenkovic J., Milojkovic M., Mitic D. et al. Interaction of thrombophilic SNPs in patients with unexplained infertility-multifactor dimensionality reduction (MDR) model analysis. J Assist Reprod Genet. 2020;37(6):1449–58. https://doi.org/10.1007/s10815-020-01808-4.; Santos T.D.S., Ieque A.L., de Carvalho H.C. et al. Antiphospholipid syndrome and recurrent miscarriage: A systematic review and meta-analysis. J Reprod Immunol. 2017;123:78–87. https://doi.org/10.1016/j.jri.2017.09.007.; El Hasbani G., Khamashta M., Uthman I. Antiphospholipid syndrome and infertility. Lupus. 2020;29(2):105–17. https://doi.org/10.1177/0961203319893763.; Qublan H.S., Eid S.S., Ababneh H.A. et al. Acquired and inherited thrombophilia: implication in recurrent IVF and embryo transfer failure. Hum Reprod. 2006;21(10):2694–8. https://doi.org/10.1093/humrep/del203.; Nesbit C., Gunalp C., Zhang J. et al. Longitudinal assessment of coagulation potential before, during, and following an in vitro fertilization cycle. Thromb Res. 2024;238:97–102. https://doi.org/10.1016/j.thromres.2024.04.020.; Azem F., Many A., Ben Ami I. et al. Increased rates of thrombophilia in women with repeated IVF failures. Hum Reprod. 2004;19(2):368–70. https://doi.org/10.1093/humrep/deh069.; Hansen A.T., Kesmodel U.S., Juul S., Hvas A.M. Increased venous thrombosis incidence in pregnancies after in vitro fertilization. Hum Reprod. 2014;29(3):611–7. https://doi.org/10.1093/humrep/det458.; Refsum H., Nurk E., Smith A.D. et al. The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease. J Nutr. 2006;136(6 Suppl):1731S–1740S. https://doi.org/10.1093/jn/136.6.1731S.; Fuchs H.E., O'Connell K., Du M. et al. Vitamin B12 supplementation and vitamin B12 blood serum levels: evaluation of effect modification by gender and smoking status. Nutr Cancer. 2022;74(7):2373–83. https://doi.org/10.1080/01635581.2021.2007271.; Bazzano L.A., He J., Muntner P. et al. Relationship between cigarette smoking and novel risk factors for cardiovascular disease in the United States. Ann Intern Med. 2003;138(11):891–7. https://doi.org/10.7326/0003-4819-138-11-200306030-00010.; Villani M., Dentali F., Colaizzo D. et al. Pregnancy-related venous thrombosis: comparison between spontaneous and ART conception in an Italian cohort. BMJ Open. 2015;5(10):e008213. https://doi.org/10.1136/bmjopen-2015-008213.; Rosendaal F.R. Risk factors for venous thrombotic disease. Thromb Haemost. 1999;82(2):610–9.; Grandone E., Ageno W. The legacy of Edwards and Steptoe and the windy roads of assisted reproduction: where do we stand with venous thromboembolism? Thromb Haemost. 2023;123(3):267–9. https://doi.org/10.1055/a-1996-1341.; Yinon Y., Pauzner R., Dulitzky M. et al. Safety of IVF under anticoagulant therapy in patients at risk for thrombo-embolic events. Reprod Biomed Online. 2006;12(3):354–8. https://doi.org/10.1016/s1472-6483(10)61009-7.; Bates S.M., Greer I.A., Middeldorp S. et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e691S–e736S. https://doi.org/10.1378/chest.11-2300.; Grandone E., Piazza G. Thrombophilia, inflammation, and recurrent pregnancy loss: a case-based review. Semin Reprod Med. 2021;39(1–02):62–8. https://doi.org/10.1055/s-0041-1731827.; Sticchi E., Romagnuolo I., Cellai A.P. et al. Fibrinolysis alterations in infertile women during controlled ovarian stimulation: influence of BMI and genetic components. Thromb Res. 2012;130(6):919–24. https://doi.org/10.1016/j.thromres.2012.07.005.; Gurunath S., Vinekar S., Biliangady R. Assisted reproductive techniques in a patient with history of venous thromboembolism: a case report and review of literature. J Hum Reprod Sci. 2018;11(2):193–7. https://doi.org/10.4103/jhrs.JHRS5817.; Westerlund E., Antovic A., Hovatta O. et al. Changes in von Willebrand factor and ADAMTS13 during IVF. Blood Coagul Fibrinolysis. 2011;22(2):127–31. https://doi.org/10.1097/MBC.0b013e32834363ea.; https://www.gynecology.su/jour/article/view/2494

Availability: https://www.gynecology.su/jour/article/view/2494
https://doi.org/10.17749/2313-7347/ob.gyn.rep.2025.656

View record from BASE

2

Academic Journal

A multi-centre phase 3 study comparing efficacy and safety of Bemfola® versus Gonal-f® in women undergoing ovarian stimulation for IVF

Authors: Rettenbacher, M., Andersen, A.N., Garcia-Velasco, J.A.

Source: Репродуктивная эндокринология, Iss 58, Pp 118-124 (2021)
Reproductive Endocrinology; No. 58 (2021); 118-124
Репродуктивная эндокринология; № 58 (2021); 118-124
Репродуктивна ендокринологія; № 58 (2021); 118-124

Subject Terms: изъятые ооциты, стимуляція яєчників, оплодотворение in vitro, рекомбінантний фолікулостимулюючий гормон, Gynecology and obstetrics, стимуляция яичников, ICSI, oocytes retrieved, ovarian stimulation, 3. Good health, рекомбинантный фолликулостимулирующий гормон, 03 medical and health sciences, интрацитоплазматическая инъекция спермы, 0302 clinical medicine, IVF, інтрацитоплазматична ін'єкція сперми, ivf, RG1-991, запліднення in vitro, вилучені ооцити, icsi, r-FSH, r-fsh

File Description: application/pdf

Access URL: http://reproduct-endo.com/article/download/232940/231713
https://doaj.org/article/957e8f5399d84e5caa7f6b220bbb49a1
http://reproduct-endo.com/article/view/232940

View record at OpenAIRE Full Text Finder

3

Academic Journal

Effectiveness of in vitro fertilization (IVF/ICSI) programs in patients with a predicted poor ovarian response

Source: Ukrainian Journal «Health of Woman»; No. 4(161) (2022): Ukrainian Journal Health of Woman; 27-31
Ukrainian Journal «Health of Woman»; № 4(161) (2022): Ukrainian Journal Health of Woman; 27-31
Український журнал "Здоров'я жінки"; № 4(161) (2022): Український журнал Здоров’я жінки; 27-31

Subject Terms: assisted reproductive technologies, сечові та рекомбінантні гонадотропіни, стимуляція яєчників, стимуляция яичников, ovarian stimulation, 3. Good health, urinary and recombinant gonadotropins, effectiveness of pregnancy onset, ефективність настання вагітності, эффективность наступления беременности, безпліддя, бесплодие, вспомогательные репродуктивные технологии, мочевые и рекомбинантные гонадотропины, infertility, допоміжні репродуктивні технології

File Description: application/pdf

Access URL: http://ujhw.med-expert.com.ua/article/view/267969

4

Academic Journal

Efficacy of embryological stage of in vitro fertilization in female patients with predicted poor ovarian response

Source: Ukrainian Journal «Health of Woman»; No. 1(158) (2022): Ukrainian Journal Health of Woman; 8-13
Ukrainian Journal «Health of Woman»; № 1(158) (2022): Ukrainian Journal Health of Woman; 8-13
Український журнал "Здоров'я жінки"; № 1(158) (2022): Український журнал Здоров’я жінки; 8-13

Subject Terms: assisted reproductive technologies, рекомбинантные гонадотропины, репродуктивные технологии, сечові гонадотропіни, контрольована стимуляція яєчників, controlled ovarian stimulation, recombinant gonadotropins, 3. Good health, контролируемая стимуляция яичников, мочевые гонадотропины, безпліддя, urinary gonadotropins, бесплодие, рекомбінантні гонадотропіни, infertility, допоміжні репродуктивні технології

File Description: application/pdf

Access URL: http://ujhw.med-expert.com.ua/article/view/256463

5

Academic Journal

Analysis of somatic and reproductive history in patients with prognostically poor response of the testicles to gonadotropin stimulation ; Анализ соматического и репродуктивного анамнеза пациенток с прогнозируемым слабым ответом яичников на стимуляцию гонадотропинами ; Аналіз соматичного та репродуктивного анамнезу пацієнток із прогнозованою слабкою відповіддю яєчників на стимуляцію гонадотропінами

Authors: Чайка, О.О.

Source: Reproductive health of woman; No. 9-10 (2021); 42-47 ; Reproductive health of woman; № 9-10 (2021); 42-47 ; Репродуктивне здоров'я жінки; № 9-10 (2021); 42-47 ; 2708-8731 ; 2708-8723

Subject Terms: безпліддя, допоміжні репродуктивні технології, контрольована стимуляція яєчників, гонадотропіни, соматичний анамнез, репродуктивний анамнез, бесплодие, вспомогательные репродуктивные технологии, контролируемая стимуляция яичников, гонадотропины, соматический анамнез, репродуктивный анамнез, infertility assisted reproductive technologies, controlled ovarian stimulation, gonadotropins, somatic history, reproductive history

File Description: application/pdf

Relation: https://repro-health.com.ua/article/view/252589/249925

Availability: https://repro-health.com.ua/article/view/252589
https://doi.org/10.30841/2708-8731.9-10.2021.252589

View record from BASE

6

Academic Journal

Analysis of somatic and reproductive history in patients with prognostically poor response of the testicles to gonadotropin stimulation

Source: Репродуктивне здоров'я жінки; № 9-10 (2021); 42-47
Reproductive health of woman; № 9-10 (2021); 42-47
Reproductive health of woman; No. 9-10 (2021); 42-47

Subject Terms: infertility assisted reproductive technologies, somatic history, гонадотропіни, контрольована стимуляція яєчників, controlled ovarian stimulation, соматический анамнез, 3. Good health, контролируемая стимуляция яичников, репродуктивний анамнез, гонадотропины, соматичний анамнез, безпліддя, бесплодие, вспомогательные репродуктивные технологии, репродуктивный анамнез, допоміжні репродуктивні технології, gonadotropins, reproductive history

File Description: application/pdf

Access URL: http://repro-health.com.ua/article/view/252589

View record at OpenAIRE

7

Academic Journal

THE USE OF CALCIUM IONOPHORE IN IVF – ICSI PROTOCOLS IN PATIENTS WITH A REDUCED REPRODUCTIVE PROGNOSIS ; ПРИМЕНЕНИЕ КАЛЬЦИЯ ИОНОФОРА У ПАЦИЕНТОК СО СНИЖЕННЫМ РЕПРОДУКТИВНЫМ ПРОГНОЗОМ В ПРОТОКОЛАХ ВРТ ; ЗАСТОСУВАННЯ КАЛЬЦІЮ ІОНОФОРУ У ПАЦІЄНТОК ЗІ ЗНИЖЕНИМ РЕПРОДУКТИВНИМ ПРОГНОЗОМ У ПРОТОКОЛАХ ДРТ

Authors: Strelko, H. V., Aidin, B., Ulanova, V. V., Maliuta, O. V., Pischana, T. H., Korotkevych, N. V., Korobko, M. Yu.

Source: Actual Problems of Pediatry, Obstetrics and Gynecology; No. 1 (2019); 131-135 ; Актуальные вопросы педиатрии, акушерства и гинекологии; № 1 (2019); 131-135 ; Актуальні питання педіатрії, акушерства та гінекології; № 1 (2019); 131-135 ; 2415-301X ; 2411-4944 ; 10.11603/24116-4944.2019.1

Subject Terms: controlled ovarian stimulation, corinollitropin-alpha, Ca ionophore, IVF, ICSI, контролированная стимуляция яичников, корифоллитропин альфа, Са ионофор, ЭКО, контрольована стимуляція яєчників, корифолітропін альфа, Са іонофор, ЕКЗ

File Description: application/pdf

Relation: https://ojs.tdmu.edu.ua/index.php/act-pit-pediatr/article/view/10201/9802; https://repository.tdmu.edu.ua//handle/123456789/14874

Availability: https://repository.tdmu.edu.ua//handle/123456789/14874
https://ojs.tdmu.edu.ua/index.php/act-pit-pediatr/article/view/10201
https://doi.org/10.11603/24116-4944.2019.1.10201

View record from BASE

8

Academic Journal

MODERN APPROACH CONCERNING CONTROLLED OVARIAN STIMULATION IN CIRCLES OF ADDITIONAL REPRODUCTIVE TECHNOLOGIES IN WOMEN WITH HIGH RISK OF OVARIAN HYPER STIMULATION SYNDROME ; СОВРЕМЕННЫЙ ПОДХОД ОТНОСИТЕЛЬНО ПРОВЕДЕНИЯ КОНТРОЛИРОВАННОЙ СТИМУЛЯЦИИ ЯИЧНИКОВ В ЦИКЛАХ ВСПОМОГАТЕЛЬНЫХ РЕПРОДУКТИВНЫХ ТЕХНОЛОГИЙ У ЖЕНЩИН С ВЫСОКИМ РИСКОМ СИНДРОМА ГИПЕРСТИ - МУЛЯЦИИ ЯИЧНИКОВ. ; СУЧАСНИЙ ПІДХІД ЩОДО ПРОВЕДЕННЯ КОНТРОЛЬОВАНОЇ СТИМУЛЯЦІЇ ЯЄЧНИКІВ У ЦИКЛАХ ДОПОМІЖНИХ РЕПРОДУКТИВНИХ ТЕХНОЛОГІЙ У ЖІНОК ІЗ ВИСОКИМ РИЗИКОМ СИНДРОМУ ГІПЕРСТИМУЛЯЦІЇ ЯЄЧНИКІВ.

Authors: Ayziatulova, E. M.

Source: Actual Problems of Pediatry, Obstetrics and Gynecology; No. 1 (2016) ; Актуальные вопросы педиатрии, акушерства и гинекологии; № 1 (2016) ; Актуальні питання педіатрії, акушерства та гінекології; № 1 (2016) ; 2415-301X ; 2411-4944 ; 10.11603/24116-4944.2016.1

Subject Terms: assisted reproductive technology, controlled ovarian stimulation, antagonists gonadotropin-releasing hormone, progesterone, ovarian hyperstimulation syndrome, вспомогательные репродуктивные технологии, контролируемая стимуляция яичников, антагонисты гонадотропин-рилизинг-гормона, прогестерон, синдром гиперстимуляции яичников, допоміжні репродуктивні технології, контрольована стимуляція яєчників, антагоністи гонадотропін- рилізинг-гормону, синдром гіперстимуляції яєчників